4
Changes in Ownership
PDS Biotechnology Corp Filed Acc 0001127602-17-033971
President and CEO sold 7,500 shares at an average $9.86 ($73,925)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Leuthner Brian A President and CEO | 2017-12-01 | Sale | −2,500 | $9.92 | $24,800 | 95,236 | D |
| Leuthner Brian A President and CEO | 2017-12-04 | Sale | −2,500 | $9.97 | $24,925 | 92,736 | D |
| Leuthner Brian A President and CEO | 2017-12-05 | Sale | −2,500 | $9.68 | $24,200 | 90,236 | D |
| Open-market sales · 7,500 sh · avg $9.86 · $73,925 | |||||||
Loading xslF345X03/form4.xml…